BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10233038)

  • 1. Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs.
    Woods RL; Jones MJ
    Am J Physiol; 1999 May; 276(5):R1443-52. PubMed ID: 10233038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats.
    Thomas CJ; Head GA; Woods RL
    J Hypertens; 1999 Jun; 17(6):801-6. PubMed ID: 10459878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide infusion causes vasoconstriction after autonomic blockade in conscious dogs.
    Woods RL; Anderson WP
    Am J Physiol; 1990 Oct; 259(4 Pt 2):R813-22. PubMed ID: 2145778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep.
    Thomas CJ; May CN; Sharma AD; Woods RL
    Am J Physiol Regul Integr Comp Physiol; 2001 Jan; 280(1):R282-8. PubMed ID: 11124162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do natriuretic peptides modify arterial baroreflexes in sheep?
    Thomas CJ; Woods RL
    Exp Physiol; 2004 Nov; 89(6):709-15. PubMed ID: 15364878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of natriuretic peptides in healthy men.
    Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
    J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs.
    Lainchbury JG; Burnett JC; Meyer D; Redfield MM
    Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H33-40. PubMed ID: 10644581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor?
    Brunner-La Rocca HP; Woods RL; Kaye DM; Hastings J; Thomas CJ; Lambert E; Esler MD
    J Hypertens; 2002 Jun; 20(6):1195-201. PubMed ID: 12023691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptides buffer renin-dependent hypertension.
    Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity of natriuretic peptide coinfusions; no evidence for unique effects of BNP in conscious sheep.
    Charles CJ; Espiner EA; Nicholls MG; Rademaker MT; Richards AM
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):229-36. PubMed ID: 10028930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional blood flow effects of ANP in conscious dogs: preferential gastrointestinal vasoconstriction.
    Woods RL; Smolich JJ
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1961-9. PubMed ID: 1836313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atrial natriuretic factor on the vasoconstrictor actions of the renin-angiotensin system in conscious rats.
    Lappe RW; Todt JA; Wendt RL
    Circ Res; 1987 Jul; 61(1):134-40. PubMed ID: 3038365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of natriuretic peptides in regulation of conduit artery distensibility.
    Schmitt M; Qasem A; McEniery C; Wilkinson IB; Tatarinoff V; Noble K; Klemes J; Payne N; Frenneaux MP; Cockcroft J; Avolio A
    Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1167-71. PubMed ID: 15317675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac natriuretic peptides and pancreatic islet blood flow in anesthetized rats.
    Carlsson PO; Andersson A; Jansson L
    Horm Metab Res; 2001 Mar; 33(3):181-5. PubMed ID: 11355754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor-induced systemic vasoconstriction in conscious dogs, rats, and monkeys.
    Shen YT; Young MA; Ohanian J; Graham RM; Vatner SF
    Circ Res; 1990 Mar; 66(3):647-61. PubMed ID: 1968363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoconstrictor actions of atrial natriuretic peptide in the splanchnic circulation of anesthetized dogs.
    Woods RL
    Am J Physiol; 1998 Dec; 275(6):R1822-32. PubMed ID: 9843871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.